Overview

Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The study design of this trial is open-label, randomized, multi-center, parallel-group study.
Phase:
Phase 4
Details
Lead Sponsor:
Handok Inc.
Handok Pharmaceuticals Co., Ltd.
Treatments:
Glimepiride
Metformin